Monthly Injectable BUP for MA Use Disorder (MURB) Trial
Public ClinicalTrials.gov record NCT05283304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Placebo-controlled Trial of Monthly Injectable Buprenorphine (BUP) for Methamphetamine (MA) Use Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a 12-week randomized, double-blind, placebo-controlled trial that will investigate the use of injectable buprenorphine (BUP-Inj) compared to injectable placebo (PBO-Inj) for the treatment of methamphetamine use disorder (MUD) among individuals with mild co-use of opioids.
Study identification
- NCT ID
- NCT05283304
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 23, 2023
- Primary completion
- Oct 19, 2023
- Completion
- Nov 18, 2023
- Last update posted
- Mar 20, 2025
2023
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Vine Street Clinic | Los Angeles | California | 90038 | — |
| Highland Hospital, Alameda Health System | Oakland | California | 94602 | — |
| Oklahoma State University, Center for Health Sciences | Tulsa | Oklahoma | 74107 | — |
| CODA | Portland | Oregon | 97214 | — |
| UTSW Medical Center, Center for Depression Research and Clinical Care | Dallas | Texas | 75247 | — |
| University of Washington Medicine-Harborview Medical Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Methamphetamine-dependence trials
Other public records listing Methamphetamine-dependence. Sorted by last update posted; newest first. Not a recommendation.
- NCT07204249: Glutide for Ending Methamphetamine Recruiting
- NCT06233799: Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder Recruiting
- NCT04927143: Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives Recruiting
- NCT06027814: MHealth Incentivized Adherence Plus Patient Navigation Active, not recruiting
- NCT04317482: The Human Stress Response in a Simulated ED Setting Active, not recruiting
- NCT05162391: Inflammation in Methamphetamine and STIs (IMSTI) Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05283304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05283304 live on ClinicalTrials.gov.